![Mardi Dier](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mardi Dier
Finansdirektör/CFO på
MADRIGAL PHARMACEUTICALS, INC.
Förmögenhet: 53 300 $ per 2026-06-30
Profil
Mardi C.
Dier is Chief Financial Officer & Senior Vice President at Madrigal Pharmaceuticals, Inc. since 2024.
Independent Director at Synthekine, Inc. since 2021.
Independent Director at Oric Pharmaceuticals, Inc. since 2020.
Advisor at Healthcare Royalty Management LLC.
Formerly Independent Director at Adamas Pharmaceuticals LLC from 2017 to 2021.
Chief Business Officer at ACELYRIN, Inc. from 2022 to 2023.
Chief Financial Officer & Executive Vice President at Ultragenyx Pharmaceutical, Inc. from 2020 to 2022.
CFO, Chief Business Officer & Executive Vice President at Portola Pharmaceuticals LLC from 2018 to 2020.
Vice President-Investor Relations at Chiron Corp.
from 2003 to 2006.
Independent Director at Prelude Therapeutics, Inc. from 2020 to 2025.
Director-Investment Banking at Prudential Equity Group LLC from 1994 to 2001.
Director-Investment Banking at Prudential Securities.
Director at Futures Strategic Trust.
Director at Jewish Vocational Service, Inc. Senior Accountant at KPMG LLP and KPMG Peat Marwick LLP from 1986 to 1990.
Education includes an undergraduate degree from Stanford University in 1986 and an MBAistration from UCLA Anderson School of Management in 1992.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2025-06-12 | 10 000 ( 0,02 % ) | 53 300 $ | 2026-06-30 | |
| 2026-04-01 | 0 ( -.--% ) | - $ | 2026-06-30 | |
| 2026-03-31 | 0 ( -.--% ) | - $ | 2026-06-30 |
Aktiva positioner av Mardi Dier
| Företag | Position | Start |
|---|---|---|
| ORIC PHARMACEUTICALS, INC. | Direktör/Styrelseledamot | 2020-02-01 |
| MADRIGAL PHARMACEUTICALS, INC. | Finansdirektör/CFO | 2024-03-11 |
Healthcare Royalty Management LLC
 Healthcare Royalty Management LLC Investment ManagersFinance Healthcare Royalty invests in companies located in the United States. The firm targets companies operating in the field of biopharmaceutical, biotechnology and medical device sectors. It provides financing for buyout transactions in the form of royalty monetization, corporate financing and debt. | Konsult / Rådgivare | - |
Synthekine, Inc.
 Synthekine, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops immunotherapies | Direktör/Styrelseledamot | 2021-06-03 |
Tidigare kända positioner av Mardi Dier
| Företag | Position | Slut |
|---|---|---|
| PRELUDE THERAPEUTICS INCORPORATED | Direktör/Styrelseledamot | 2025-10-17 |
| ACELYRIN, INC. | Finansdirektör/CFO | 2023-08-02 |
| ULTRAGENYX PHARMACEUTICAL INC. | Finansdirektör/CFO | 2022-11-15 |
| ADAMAS PHARMACEUTICALS, INC. | Direktör/Styrelseledamot | 2021-06-09 |
| PORTOLA PHARMACEUTICALS, INC. | Finansdirektör/CFO | 2020-07-01 |
Mardi Diers utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
83
Första gradens relationer
18
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 18 |
|---|---|
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Provides nucleic acid test for blood screening | Health Technology |
Futures Strategic Trust
 Futures Strategic Trust Investment Banks/BrokersFinance Invests in commodities contracts | Finance |
Prudential Securities
 Prudential Securities Investment Banks/BrokersFinance Provides brokerage services | Finance |
Portola Pharmaceuticals LLC
 Portola Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of novel therapeutics | Health Technology |
Adamas Pharmaceuticals LLC
 Adamas Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets therapeutics for neurological diseases | Health Technology |
Ultragenyx Pharmaceutical, Inc.
 Ultragenyx Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel products for the treatment of serious rare and ultra-rare genetic diseases | Health Technology |
KPMG LLP
 KPMG LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, tax and advisory services | Commercial Services |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
KPMG Peat Marwick LLP
 KPMG Peat Marwick LLP Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Commercial Services |
Prudential Equity Group LLC
 Prudential Equity Group LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Healthcare Royalty Management LLC
Healthcare Royalty Management LLC Investment ManagersFinance Healthcare Royalty invests in companies located in the United States. The firm targets companies operating in the field of biopharmaceutical, biotechnology and medical device sectors. It provides financing for buyout transactions in the form of royalty monetization, corporate financing and debt. | Finance |
Jewish Vocational Service, Inc.
 Jewish Vocational Service, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a organization that provides adult education and workforce development services | Commercial Services |
UCLA Anderson School of Management
 UCLA Anderson School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oric Pharmaceuticals, Inc.
 Oric Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops pharmaceutical products | Health Technology |
Prelude Therapeutics, Inc.
 Prelude Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops medicines targeting chromatin function to treat cancer and rare diseases | Health Technology |
Madrigal Pharmaceuticals, Inc.
 Madrigal Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops small-molecule drugs for cardiovascular, metabolic and liver diseases | Health Technology |
Synthekine, Inc.
Synthekine, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops immunotherapies | Health Technology |
ACELYRIN, Inc.
 ACELYRIN, Inc. Pharmaceuticals: MajorHealth Technology Operates as late-stage clinical biopharmaceutical company which focuses on identifying, acquiring and accelerating the development & commercialization of medicines | Health Technology |
